Sage Therapeutics Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $59.99 on 06/12/23, with the lowest value being $10.19 on 06/11/24.
52-week price history of SAGE Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Sage Therapeutics Inc’s current trading price is -83.11% away from its 52-week high, while its distance from the 52-week low is -0.59%. The stock’s price range for this period has remained between $10.19 and $59.99. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.91 million for the day, which was noticeably higher compared to the shares’ average daily volume of 1.12 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Sage Therapeutics Inc (SAGE) has experienced a quarterly decline of -50.22% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 609.62M and boasts a workforce of 487 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 17.84, with a change in price of -16.21. Similarly, Sage Therapeutics Inc recorded 1,067,563 in trading volume during the last 100 days, posting a change of -62.28%.
SAGE Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SAGE stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
SAGE Stock Stochastic Average
As of today, the raw stochastic average of Sage Therapeutics Inc over the past 50 days is 0.67%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 1.66%. Additionally, the Stochastic %K and %D values for the company were 10.94% and 13.00%, respectively, over the past 20 days.
SAGE Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a loss of -53.25%.However, over the last six months, we can see a stronger performance of -49.38%. Over the last 30 days, the price of SAGE has leaped by -14.87%. And in the last five days, it has fallen by -5.15%.
